HomeIndustriesHealthcareMRVL, DELL Fall & PATH Rises After Earnings, PFE Discontinues Weight Loss Pill

MRVL, DELL Fall & PATH Rises After Earnings, PFE Discontinues Weight Loss Pill

Marvell (MRVL) falls after issuing soft guidance. MRVL’s 3Q adjusted EPS came in at $0.41 versus an estimated $0.40 and revenue came in at $1.42B versus an estimated $1.40B. Dell (DELL) shares are down after mixed 3Q earnings. UiPath (PATH) opens at a new 52-week high after beating earnings. Its adjusted EPS came in at $0.12 versus an estimated $0.07 and revenue came in at $325.92M versus an estimated $315.54M. Pfizer (PFE) discontinues weight loss pill trial after many experienced negative side effects. Kevin Green discusses these stories. Tune in to find out more about the stock market today.

Morning Trade Live

01 Dec 2023

SHARE

ON AIR
education
6:00 pm
Schwab 2026 Outlook
replay
12:00 am
Market Overtime
REPLAY
12:30 am
Market On Close
REPLAY
education
2:00 am
Your First Trade
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
education
5:00 am
Liz Ann Live
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Market Overtime
REPLAY
8:00 am
Market Overtime
REPLAY
8:30 am
Market On Close
REPLAY
education
10:00 am
Schwab 2026 Outlook
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Liz Ann Live
REPLAY
1:30 pm
The Wrap
REPLAY
3:00 pm
Market Overtime
REPLAY
4:00 pm
Market Overtime
REPLAY
4:30 pm
Market On Close
REPLAY
ON AIR
education
6:00 pm
Schwab 2026 Outlook
REPLAY
7:00 pm
Fast Market
REPLAY
8:00 pm
Next Gen Investing
REPLAY
education
9:00 pm
Liz Ann Live
REPLAY
9:30 pm
The Wrap
REPLAY
11:00 pm
Market Overtime
REPLAY

Schwab Network's Newsletters

Daily insights for every investor